Doxorubicin cardiotoxicity in children: Comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration
- 12 December 1998
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 31 (6) , 512-515
- https://doi.org/10.1002/(sici)1096-911x(199812)31:6<512::aid-mpo8>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.Journal of Clinical Oncology, 1997
- Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood CancerNew England Journal of Medicine, 1995
- Late doxorubicin-associated cardiotoxicity in childrenCancer, 1994
- ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.Journal of Clinical Oncology, 1992
- Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinomaCancer, 1989
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- Adriamycin cardiotoxicityThe American Journal of Surgical Pathology, 1977
- AdriamycinAnnals of Internal Medicine, 1974